JP2000507268A - ベンゾチオフェン類、それを含む製剤、および方法 - Google Patents
ベンゾチオフェン類、それを含む製剤、および方法Info
- Publication number
- JP2000507268A JP2000507268A JP9534467A JP53446797A JP2000507268A JP 2000507268 A JP2000507268 A JP 2000507268A JP 9534467 A JP9534467 A JP 9534467A JP 53446797 A JP53446797 A JP 53446797A JP 2000507268 A JP2000507268 A JP 2000507268A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- particle size
- raloxifene
- formula
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Thin Film Transistor (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.粒子状であって、該粒子が約25ミクロン未満の平均粒径を有することを 特徴とする、式I: の化合物、並びにその医薬的に許容され得る塩および溶媒和物。 2.該粒子が約5〜約20ミクロンの間の平均粒径を有する、請求項1に記載 の化合物。 3.該粒子の少なくとも約90%が約50ミクロン未満の径を有する、請求項 1または2に記載の化合物。 4.該粒子の少なくとも90%が約35ミクロン未満の径を有する、請求項3 に記載の化合物。 5.式Iの化合物がラロキシフェン塩酸塩である、請求項1〜4のいずれかに 記載の化合物。 6.実質的には、銅放射で得られた、以下のX線回折パターン: d線面間隔(オングストローム) I/Io(×100) 13.3864 71.31 9.3598 33.16 8.4625 2.08 7.3888 7.57 6.9907 5.80 6.6346 51.04 6.1717 29.57 5.9975 5.67 5.9135 9.87 5.6467 38.47 5.4773 10.54 5.2994 4.74 4.8680 4.03 4.7910 5.98 4.6614 57.50 4.5052 5.75 4.3701 9.03 4.2516 69.99 4.2059 57.64 4.1740 65.07 4.0819 12.44 3.9673 22.53 3.9318 100.00 3.8775 9.07 3.7096 33.38 3.6561 21.65 3.5576 3.36 3.5037 7.97 3.4522 18.02 3.4138 4.65 3.2738 10.23 3.1857 8.90 3.1333 6.24 3.0831 9.43 3.0025 12.13 2.9437 4.96 2.8642 7.70 2.7904 11.95 2.7246 3.05 2.6652 3.32 2.5882 7.30 を有する、溶媒和していない結晶性塩酸塩である、請求項5に記載の化合物。 7.請求項1〜5のいずれかに記載の化合物、および1つもしくはそれ以上の 医薬的に許容され得る担体、希釈剤、もしくは賦形剤を含んでなるか、または請 求項1〜5のいずれかに記載の化合物、および1つもしくはそれ以上の医薬的に 許容され得る担体、希釈剤、もしくは賦形剤を使用して製剤化した医薬品製剤。 8.1つまたはそれ以上の医薬的に許容され得る担体、希釈剤、または賦形剤 と組み合わせて、請求項1に記載の化合物、またはその医薬的に許容され得る塩 もしくは溶媒和物を含んでなるか、または請求項1に記載の化合物、またはその 医薬的に許容され得る塩もしくは溶媒和物を使用して製剤化した医薬組成物。 9.ラロキシフェンでの骨粗鬆症の処置においてバイオアベイラビリティを高 める方法であって、そのことを必要とするヒトに、請求項1〜6のいずれかに記 載の式Iの化合物、または請求項7もしくは8に記載の医薬品製剤の有効量を投 与することを含んでなる方法。 10.ラロキシフェンで血清脂質レベルを低下させる際のバイオアベイラビリ ティを高める方法であって、そのことを必要とするヒトに、請求項1〜6のいず れかに記載の式Iの化合物、または請求項7もしくは8に記載の医薬品製剤の有 効量を投与することを含んでなる方法。 11.ラロキシフェンで乳癌を予防する際のバイオアベイラビリティを高める 方法であって、そのことを必要とするヒトに、請求項1〜6のいずれかに記載の 式Iの化合物、または請求項7もしくは8に記載の医薬品製剤の有効量を投与す ることを含んでなる方法。 12.医薬品製剤を含む包装材料を含んでなる製品であって、該包装材料が、 該医薬品製剤がヒトの病状を抑制するのに有用であることを示す標識をさらに含 み、かつ該医薬品製剤が、請求項1−5のいずれかに記載の化合物を含んでなる か、または請求項1−5のいずれかに記載の化合物を使用して製剤化された製品 。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1416796P | 1996-03-26 | 1996-03-26 | |
GB9607110.5 | 1996-04-04 | ||
GBGB9607110.5A GB9607110D0 (en) | 1996-04-04 | 1996-04-04 | Benzothiopenes formulations containing same and methods |
GB60/014,167 | 1996-04-04 | ||
PCT/US1997/004259 WO1997035571A1 (en) | 1996-03-26 | 1997-03-20 | Benzothiophenes, formulations containing same, and methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008227311A Division JP2009019057A (ja) | 1996-03-26 | 2008-09-04 | ベンゾチオフェン類、それを含む製剤、および方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000507268A true JP2000507268A (ja) | 2000-06-13 |
JP2000507268A5 JP2000507268A5 (ja) | 2004-11-04 |
Family
ID=26309061
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9534467A Withdrawn JP2000507268A (ja) | 1996-03-26 | 1997-03-20 | ベンゾチオフェン類、それを含む製剤、および方法 |
JP2008227311A Withdrawn JP2009019057A (ja) | 1996-03-26 | 2008-09-04 | ベンゾチオフェン類、それを含む製剤、および方法 |
JP2013118034A Withdrawn JP2013166797A (ja) | 1996-03-26 | 2013-06-04 | ベンゾチオフェン類、それを含む製剤、および方法 |
JP2015116526A Expired - Lifetime JP6095725B2 (ja) | 1996-03-26 | 2015-06-09 | ベンゾチオフェン類、それを含む製剤、および方法 |
JP2016059108A Expired - Lifetime JP6095821B2 (ja) | 1996-03-26 | 2016-03-23 | ベンゾチオフェン類、それを含む製剤、および方法 |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008227311A Withdrawn JP2009019057A (ja) | 1996-03-26 | 2008-09-04 | ベンゾチオフェン類、それを含む製剤、および方法 |
JP2013118034A Withdrawn JP2013166797A (ja) | 1996-03-26 | 2013-06-04 | ベンゾチオフェン類、それを含む製剤、および方法 |
JP2015116526A Expired - Lifetime JP6095725B2 (ja) | 1996-03-26 | 2015-06-09 | ベンゾチオフェン類、それを含む製剤、および方法 |
JP2016059108A Expired - Lifetime JP6095821B2 (ja) | 1996-03-26 | 2016-03-23 | ベンゾチオフェン類、それを含む製剤、および方法 |
Country Status (30)
Country | Link |
---|---|
EP (2) | EP0910369B1 (ja) |
JP (5) | JP2000507268A (ja) |
CN (1) | CN1162153C (ja) |
AR (1) | AR006387A1 (ja) |
AT (1) | ATE464897T1 (ja) |
AU (1) | AU723797B2 (ja) |
BR (1) | BR9708248A (ja) |
CA (1) | CA2250191C (ja) |
CO (1) | CO4780022A1 (ja) |
CZ (1) | CZ300341B6 (ja) |
DE (1) | DE69739855D1 (ja) |
DK (1) | DK0910369T3 (ja) |
EA (1) | EA001257B1 (ja) |
ES (1) | ES2341399T3 (ja) |
HK (1) | HK1020671A1 (ja) |
ID (1) | ID19813A (ja) |
IL (2) | IL140742A (ja) |
ME (2) | ME00074B (ja) |
MY (1) | MY115533A (ja) |
NO (1) | NO320894B1 (ja) |
NZ (1) | NZ332036A (ja) |
PL (1) | PL191148B1 (ja) |
PT (1) | PT910369E (ja) |
RO (1) | RO121117B1 (ja) |
SI (1) | SI0910369T1 (ja) |
TR (1) | TR199801915T2 (ja) |
TW (1) | TW513421B (ja) |
UA (1) | UA57596C2 (ja) |
WO (1) | WO1997035571A1 (ja) |
YU (1) | YU41898A (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009019057A (ja) * | 1996-03-26 | 2009-01-29 | Eli Lilly & Co | ベンゾチオフェン類、それを含む製剤、および方法 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2219377A1 (en) * | 1996-10-30 | 1998-04-30 | Eli Lilly And Company | Improvements in or relating to the prophylaxis of breast cancer |
ZA992858B (en) | 1996-10-30 | 1999-07-29 | Lilly Co Eli | Methods of preventing breast cancer. |
EP1832583A1 (en) * | 2002-09-30 | 2007-09-12 | A/S GEA Farmaceutisk Fabrik | Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
WO2008047105A1 (en) | 2006-10-17 | 2008-04-24 | Cipla Limited | Crystalline form of benzothiophene compound and process for preparation thereof |
EP2242483B1 (en) * | 2007-12-21 | 2013-02-20 | Synthon B.V. | Raloxifene composition |
SI2373305T1 (sl) * | 2008-12-11 | 2017-09-29 | Besins Healthcare Luxembourg Sarl | Transdermalni farmacevtski sestavki, ki obsegajo serm |
EP2448562B1 (en) | 2009-07-02 | 2013-11-06 | Synthon B.V. | Raloxifene composition |
WO2011099942A1 (en) | 2010-02-09 | 2011-08-18 | Silverstone Pharma | New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy |
GB201515391D0 (en) * | 2015-08-28 | 2015-10-14 | Amazentis Sa | Compositions |
GB201515387D0 (en) * | 2015-08-28 | 2015-10-14 | Amazentis Sa | Compositions |
EP3251661B1 (en) | 2016-05-30 | 2020-12-23 | Sun Pharmaceutical Industries Limited | Raloxifene sprinkle composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995017382A1 (en) * | 1993-12-21 | 1995-06-29 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists |
JPH07277973A (ja) * | 1994-03-02 | 1995-10-24 | Eli Lilly & Co | 経口投与可能な医薬製剤 |
DE19534744A1 (de) * | 1994-09-19 | 1996-03-21 | Lilly Co Eli | Neues pharmazeutisches Produkt |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4380635A (en) | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US4418068A (en) | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
JPS63112519A (ja) * | 1986-10-28 | 1988-05-17 | Shin Etsu Chem Co Ltd | ニフエジピン製剤の製造方法 |
NL9000634A (nl) * | 1990-03-20 | 1991-10-16 | Catharina Ziekenhuis Stichting | Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding. |
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
EP0616841B1 (en) * | 1992-10-09 | 1998-12-23 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Production method for fine granulate |
US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
US5482950A (en) * | 1993-10-15 | 1996-01-09 | Eli Lilly And Company | Methods for lowering serum cholesterol |
US5478847A (en) | 1994-03-02 | 1995-12-26 | Eli Lilly And Company | Methods of use for inhibiting bone loss and lowering serum cholesterol |
US5567820A (en) * | 1994-05-20 | 1996-10-22 | Eli Lilly And Company | Glucopyranoside benzothiophenes |
US5494920A (en) | 1994-08-22 | 1996-02-27 | Eli Lilly And Company | Methods of inhibiting viral replication |
US5494929A (en) * | 1995-01-12 | 1996-02-27 | Eli Lilly And Company | Methods of inhibiting growth hormone effects |
US5532254A (en) * | 1995-06-07 | 1996-07-02 | Eli Lilly And Company | Modulation of calcium channels using benzothiophenes |
CZ300341B6 (cs) * | 1996-03-26 | 2009-04-22 | Eli Lilly And Company | Farmaceutická kompozice obsahující raloxifen |
-
1997
- 1997-03-20 CZ CZ0305398A patent/CZ300341B6/cs not_active IP Right Cessation
- 1997-03-20 DK DK97915139.6T patent/DK0910369T3/da active
- 1997-03-20 CN CNB971932492A patent/CN1162153C/zh not_active Expired - Lifetime
- 1997-03-20 ME MEP-2008-183A patent/ME00074B/me unknown
- 1997-03-20 EP EP97915139A patent/EP0910369B1/en not_active Revoked
- 1997-03-20 IL IL140742A patent/IL140742A/en not_active IP Right Cessation
- 1997-03-20 CA CA002250191A patent/CA2250191C/en not_active Expired - Fee Related
- 1997-03-20 TR TR1998/01915T patent/TR199801915T2/xx unknown
- 1997-03-20 EP EP09165873A patent/EP2266560A1/en not_active Withdrawn
- 1997-03-20 SI SI9730794T patent/SI0910369T1/sl unknown
- 1997-03-20 AT AT97915139T patent/ATE464897T1/de active
- 1997-03-20 RO RO98-01419A patent/RO121117B1/ro unknown
- 1997-03-20 PT PT97915139T patent/PT910369E/pt unknown
- 1997-03-20 WO PCT/US1997/004259 patent/WO1997035571A1/en not_active Application Discontinuation
- 1997-03-20 UA UA98095028A patent/UA57596C2/uk unknown
- 1997-03-20 NZ NZ332036A patent/NZ332036A/en not_active IP Right Cessation
- 1997-03-20 ES ES97915139T patent/ES2341399T3/es not_active Expired - Lifetime
- 1997-03-20 IL IL12632097A patent/IL126320A/en not_active IP Right Cessation
- 1997-03-20 EA EA199800865A patent/EA001257B1/ru not_active IP Right Cessation
- 1997-03-20 AU AU22154/97A patent/AU723797B2/en not_active Expired
- 1997-03-20 PL PL329051A patent/PL191148B1/pl unknown
- 1997-03-20 DE DE69739855T patent/DE69739855D1/de not_active Expired - Lifetime
- 1997-03-20 JP JP9534467A patent/JP2000507268A/ja not_active Withdrawn
- 1997-03-20 ME MEP-183/08A patent/MEP18308A/xx unknown
- 1997-03-20 BR BR9708248A patent/BR9708248A/pt active IP Right Grant
- 1997-03-21 CO CO97015459A patent/CO4780022A1/es unknown
- 1997-03-24 MY MYPI97001237A patent/MY115533A/en unknown
- 1997-03-24 ID IDP970956A patent/ID19813A/id unknown
- 1997-03-25 AR ARP970101196A patent/AR006387A1/es not_active Application Discontinuation
- 1997-03-26 TW TW086103861A patent/TW513421B/zh not_active IP Right Cessation
-
1998
- 1998-09-24 NO NO19984444A patent/NO320894B1/no not_active IP Right Cessation
- 1998-09-25 YU YU41898A patent/YU41898A/sh unknown
-
1999
- 1999-10-27 HK HK99104833.5A patent/HK1020671A1/xx not_active IP Right Cessation
-
2008
- 2008-09-04 JP JP2008227311A patent/JP2009019057A/ja not_active Withdrawn
-
2013
- 2013-06-04 JP JP2013118034A patent/JP2013166797A/ja not_active Withdrawn
-
2015
- 2015-06-09 JP JP2015116526A patent/JP6095725B2/ja not_active Expired - Lifetime
-
2016
- 2016-03-23 JP JP2016059108A patent/JP6095821B2/ja not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995017382A1 (en) * | 1993-12-21 | 1995-06-29 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists |
JPH07277973A (ja) * | 1994-03-02 | 1995-10-24 | Eli Lilly & Co | 経口投与可能な医薬製剤 |
DE19534744A1 (de) * | 1994-09-19 | 1996-03-21 | Lilly Co Eli | Neues pharmazeutisches Produkt |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009019057A (ja) * | 1996-03-26 | 2009-01-29 | Eli Lilly & Co | ベンゾチオフェン類、それを含む製剤、および方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6095821B2 (ja) | ベンゾチオフェン類、それを含む製剤、および方法 | |
JP6651489B2 (ja) | ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法 | |
JP4187423B2 (ja) | ジプラシドン組成物 | |
US6458811B1 (en) | Benzothiophenes formulations containing same and methods | |
US8808751B2 (en) | Methods for the preparation of biologically active compounds in nanoparticulate form | |
TW201711687A (zh) | 帕博西里之固態劑型 | |
JPH07304661A (ja) | 1,1,2−トリフェニルブタ−1−エン誘導体類を使用する子宮内膜炎及び子宮類線維腫疾患の抑制法 | |
US20100034885A1 (en) | Formulations containing glimepiride and/or its salts | |
KR100514014B1 (ko) | 벤조티오펜,그를함유한제제및방법 | |
JPH11513665A (ja) | プラスミノーゲンアクチベーターインヒビター1の阻害方法 | |
MXPA99005524A (en) | Ziprasid formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031209 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20031209 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070904 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071204 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080121 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080104 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080129 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080904 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081030 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090326 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091013 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091022 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111111 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111122 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120620 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120629 Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120629 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120720 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120731 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120821 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120829 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120919 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20130109 |